Eight Roads, a Shangai, China-based global investment firm backed by Fidelity, launched its US$400m latest healthcare fund for China.
Eight Roads China Healthcare Fund V will follow Eight Roads’ core strategy of healthcare investments in China, which is to develop a comprehensive healthcare ecosystem across the industry value chain and around critical diseases.
Led by Daniel Auerbach, Senior Managing Partner and Head of Global Ventures, and Jarlon Tsang, Managing Partner and Head of China at Eight Roads, the new fund will invest in and build innovative and transformational healthcare and life science companies with disruptive technologies and innovative business models that address the unmet market demand. It will primarily focus on early-stage investment opportunities in the healthcare industry, covering therapeutics, med tech, healthcare services and healthcare IT/digital health.
Redirecting to Anterra Capital Announces $175 Million Initial Closing of Second Global Food and Agriculture Technology Fund
q8dailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from q8dailynews.com Daily Mail and Mail on Sunday newspapers.
Eight Roads launches its new US$400 million healthcare fund for China
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.